CUBE vs NPCE · P/E 25, rev $1.07B vs rev $79.9M
CubeSmart (CUBE) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the CUBE and NPCE stock pages for the full models.
Not investment advice.